Novo Nordisk, a Danish multinational pharmaceutical company, has launched “My$99Insulin Program” amid ongoing high insulin-pricing debates for patients with diabetes.
The program includes approved generic versions of insulin (NovoLog and NovoLog Mix) manufactured by the company and an “Immediate Supply” option.
With the My$99Insulin Program, diabetic patients can buy up to three vials or two packs of FlexPen or FlexTouch or PenFill pens of any combination of Novo Nordisk insulin for $99.
The program requires enrolling at NovoCare.com. Upon registration, patients will receive an online card or a card that can be emailed to them. The downloadable card can be redeemed at pharmacies with a prescription to purchase insulin.
All diabetic patients, irrespective of having health insurance or not, are eligible for the My$99Insulin Program.
NovoLog and NovoLog Mix are now stocked at the wholesale level and you can order them at their pharmacy.
Anyone who might be at risk of rationing insulin can choose the Immediate Supply option. Patients can visit the NovoCare.com website or call 1-888-668-6463. The company will offer a one-time, immediate supply of up to three vials or two packs of pens of Novo Nordisk insulin for free with a prescription.
Doug Langa, president of Novo Nordisk, said, “We know some people still struggle to afford their insulin and we want to help.”
“We’ve talked to people, including those who have been critical of us, and it’s clear there is no one solution that will work for everyone and people need options,” he added. “That’s why today, we have made available additional options recognizing the different situations that make insulin unaffordable or inaccessible.” Meanwhile, some states have been making efforts to bring down insulin prices. In fact, Colorado has capped insulin prices at $100 per month, which has already gone into effect.
